CV
OXFD

Clarus Ventures’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Clarus Ventures’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-445,093
Closed -$6.89M – 6
2017
Q1 		$6.89M Sell
445,093
-714,332
-62% -$10.2M 5.13% 4
2016
Q4 		$17.3M Sell
1,159,425
-993,667
-46% -$13.9M 11.42% 3
2016
Q3 		$27M Hold
2,153,092
– – 16.62% 2
2016
Q2 		$19.4M Hold
2,153,092
– – 16.95% 2
2016
Q1 		$21.3M Hold
2,153,092
– – 16.02% 2
2015
Q4 		$24.8M Hold
2,153,092
– – 17.35% 2
2015
Q3 		$29.1M Sell
2,153,092
-14,285
-0.7% -$194K 16.72% 2
2015
Q2 		$30M Sell
2,167,377
-203,951
-9% -$2.76M 13.2% 4
2015
Q1 		$33.4M Sell
2,371,328
-207,734
-8% -$2.83M 13.88% 4
2014
Q4 		$35.1M Hold
2,579,062
– – 10.03% 5
2014
Q3 		$39.4M Hold
2,579,062
– – 15.71% 4
2014
Q2 		$43.4M Hold
2,579,062
– – 15.41% 4
2014
Q1 		$51.8M Hold
2,579,062
– – 14.98% 4
2013
Q4 		$50M Buy
+2,579,062
New +$45.6M 14.12% 4

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return